We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

DOJ Ends J&J Blood Reagent Price-Fixing Probe

Law360, New York (January 24, 2011, 1:45 PM EST) -- The U.S. Department of Justice has closed a criminal antitrust investigation into a Johnson & Johnson subsidiary over an alleged conspiracy to fix the prices of blood reagents, although a multidistrict litigation against the company continues.

Ortho-Clinical Diagnostics Inc. said the DOJ had informally notified the company that the investigation was closed in a Jan. 14 filing in a related multidistrict litigation in the U.S. District Court for the Eastern District of Pennsylvania.

The Rochester, N.Y.-based health care company first disclosed the DOJ investigation in a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.